The Australian government is set to ban pharmacists from compounding replicas of popular weight loss drugs such as Ozempic and Mounjaro, citing safety concerns.
Compounding is a process whereby a pharmacist mixes various ingredients to emulate another drug. It is usually done because the medicine needs to be tailored to suit a particular patient, such as someone who may be allergic to a particular ingredient or needs a different dose than is commercially available.